Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | TSHR | P16473 | 4/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.33 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | CETP | P11597 | 4/20 | 0.33 |
| ▸ | THRB | P10828 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | GMNN | O75496 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2839828 | 0.86 | MEN1 (0.52) | MEN1KMT2ACYP3A4ALDH1A1TSHR | |
| SCHEMBL7995015 | 0.83 | MEN1 (0.36) | MEN1KMT2ACYP3A4ALDH1A1TSHR | |
| SCHEMBL9080744 | 0.82 | MEN1 (0.47) | MEN1KMT2ACYP3A4ALDH1A1CYP2D6 | |
| SCHEMBL28921995 | 0.80 | MEN1 (0.50) | MEN1KMT2ACYP3A4ALDH1A1TSHR | |
| SCHEMBL2118018 | 0.72 | MEN1 (0.41) | MEN1KMT2ACYP3A4ALDH1A1TSHR | |
| SCHEMBL2118020 | 0.72 | MEN1 (0.41) | MEN1KMT2ACYP3A4ALDH1A1TSHR | |
| SCHEMBL28972980 | 0.72 | MEN1 (0.41) | MEN1KMT2ACYP3A4ALDH1A1TSHR | |
| SCHEMBL15547328 | 0.71 | ABCG2 (0.39) | MEN1KMT2ACYP3A4ALDH1A1TSHR | |
| SCHEMBL5132095 | 0.71 | FAAH (0.50) | MEN1KMT2ACYP3A4ALDH1A1TSHR | |
| SCHEMBL14481074 | 0.69 | ABCG2 (0.41) | MEN1KMT2ACYP3A4ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102137668-B | Pyrazolopyridine Derivatives as NADPH Oxidase Inhibitors | GENKYOTEX S.A. (CH) | 2016-05-18 | — | — | CN | disclosed |
| CN-103547587-B | Transition metal complex, and organic light-emitting element, color-conversion light-emitting element, light-conversion light-emitting element, organic laser diode light-emitting element, dye laser, display device, lighting device, and electronic device using same | SHARP CORP. (JP) | 2016-05-04 | — | — | CN | disclosed |
| US-20080039319-A1 | Fungicidal Mixtures and Novel Triazolopyrimidines | BASF AKTIENGESELLSCHAFT (DE) | 2008-02-14 | — | — | US | disclosed |
| CN-1798739-A | 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators | NISSAN CHEMICAL IND LTD (JP) | 2006-07-05 | — | — | CN | disclosed |
| WO-1991000856-A2 | (1,2N) AND (3,2N)-CARBOCYCLIC-2-AMINO TETRALIN DERIVATIVES | THE UPJOHN COMPANY (US) | 1991-01-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080039319-A1 | Fungicidal Mixtures and Novel Triazolopyrimidines | ATIC, ARSA, AOC1 | MEN1 1914/4885KMT2A 903/4885CYP3A4 1117/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.